Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs.

Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs. JACC Heart Fail. 2023 08; 11(8 Pt 1):933-942.

View in: PubMed

subject areas

Atherosclerosis
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Heart Failure
Humans
Male
Veterans

authors with profiles

SALIM VIRANI
CHRISTIE BALLANTYNE
VIJAY NAMBI
WALEED KAYANI
LAURA PETERSEN
BIYKEM BOZKURT
SANKAR NAVANEETHAN
JOSEPH ROGERS